Insiders still discovering the upside: management reports the opportunity keeps revealing itself bigger in live operatio
The model's full reasoning — Q4 2022 call → NOThe question asks whether management conveys that it is still discovering new upside inside business that is already working — genuine positive surprises from live operation — and whether management is responding to those discoveries with real attention or resources now. Let me analyze the transcript for evidence of both halves: 1. Fresh discoveries coming out of live operation: - Management discusses interim analyses of ARO-APOC3 and ARO-ANG3 studies, which gave "critical insights" about how the drugs perform in different patient populations. Chris says "We have increased clarity as to the makeup of our multiple Phase 3 programs, increased clarity as to how we intend to use our late-stage drug candidates in different patient populations." - Javier says: "We now have more clarity on how each of the candidates perform in various patient populations and, importantly, where we should focus late-stage development." - Chris says: "We have increased clarity as to how large we think our pipeline of clinical candidates will be over the next few years" - The interim analyses were done to "start the important work required to prepare for Phase 3 studies" — this is a discovery from live data. However, is this a "genuine positive surprise" from live operation? The interim analyses revealed how the drugs perform in different populations, which informed where to focus. This seems more like planned data analysis from clinical trials rather than discovering new upside in the business itself. The clinical trials are the business operation, but the "discovery" here is about which patient populations to target — this is more about pipeline strategy than discovering new business opportunity from live operations. 2. Management responding with resources: - They plan multiple end-of-Phase 2 meetings and multiple Phase 3 studies - They announced "20 in '25" program - They sold olpasiran royalties to fund wholly-owned programs But the key question is whether the "discoveries" come from live operation (actual customers, orders, usage, output) versus studies/projections. The transcript is about clinical trials — the "discoveries" are from clinical data, not from market operations. There's no mention of actual customers, orders, usage, or paying customers discovering new uses. The transcript is entirely about a biotech company's clinical pipeline.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WEC | WEC Energy Group, Inc. | Q1 2024 | 2024-05-01 | A |
| PDS | Precision Drilling Corporation | Q1 2024 | 2024-04-25 | B |
| ET | Energy Transfer LP | Q2 2023 | 2023-08-02 | C+ |
| IMAX | IMAX Corporation | Q2 2023 | 2023-07-26 | B+ |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| MOMO | Hello Group Inc. | Q3 2021 | 2021-11-30 | D |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| LOPE | Grand Canyon Education, Inc. | Q2 2021 | 2021-08-08 | C |
| EMR | Emerson Electric Co. | Q3 2021 | 2021-08-04 | B+ |
| TENB | Tenable Holdings, Inc. | Q2 2021 | 2021-07-27 | A |
| UMH | UMH Properties, Inc. | Q3 2018 | 2018-11-02 | C+ |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| MKTX | MarketAxess Holdings Inc. | Q3 2017 | 2017-10-25 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| BCE | BCE Inc. | Q2 2017 | 2017-08-05 | B+ |
| BP | BP p.l.c. | Q4 2016 | 2017-02-07 | B+ |
| INGR | Ingredion Incorporated | Q1 2016 | 2016-05-01 | B+ |
BP · Q4 2016 → YESThe question is: Does management convey that it is STILL DISCOVERING NEW UPSIDE INSIDE BUSINESS THAT IS ALREADY WORKING — both discovering new positive surprises from operations AND responding with re...YES The transcript shows management conveying exactly this posture in the Oman section. They recount a genuine operational surprise—“straight wells that we had not expected,” well rates “above plan,” and liquid production “higher than planned”—that emerged while the asset was actually running.
XOM · Q2 2018 → YESThe question is: Does management convey that it is STILL DISCOVERING NEW UPSIDE INSIDE BUSINESS THAT IS ALREADY WORKING — that in the course of actually operating, selling, or delivering in the recent...YES The transcript shows management conveying exactly this posture in the Guyana section. Neil Chapman recounts fresh upward revisions to resource estimates ("now more than 4 billion... up from the 3.2 billion... just 4 months ago") and the eighth discovery ("Longtail exploration well...
LOPE · Q2 2021 → YESThe question is whether management is still discovering new upside inside a business that's already working, based on recent operations, and responding with attention or resources. YES The transcript shows management discovering fresh upside in the GCU traditional campus platform through live operations: they built three new residence halls expecting no further need next year, but current registrations reveal near-capacity demand, requiring at least two more halls to be built.